Key Financial Data Of Group

Cyfuse Biomedical K.K. - Filing #7272238

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of group
Business results of group
Net sales
54,446,000 JPY
61,112,000 JPY
374,477,000 JPY
708,245,000 JPY
137,484,000 JPY
Ordinary profit (loss)
-869,747,000 JPY
-586,187,000 JPY
-433,165,000 JPY
144,914,000 JPY
-327,492,000 JPY
Net assets
2,542,406,000 JPY
3,203,469,000 JPY
3,769,801,000 JPY
1,900,114,000 JPY
1,549,458,000 JPY
Total assets
3,518,001,000 JPY
4,214,809,000 JPY
4,815,337,000 JPY
2,646,232,000 JPY
2,196,213,000 JPY
Net assets per share
304.60
405.71
484.88
-5,183.91
-5,469.44
Basic earnings (loss) per share
-108.34
-75.42
-177.67
285.53
-658.34
Diluted earnings per share
Equity-to-asset ratio
0.709 xbrli:pure
0.760 xbrli:pure
0.783 xbrli:pure
0.718 xbrli:pure
0.705 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
0.083 xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-760,553,000 JPY
-562,296,000 JPY
-403,596,000 JPY
161,537,000 JPY
-294,001,000 JPY
Net cash provided by (used in) investing activities
-8,637,000 JPY
-19,474,000 JPY
-430,674,000 JPY
-50,583,000 JPY
-264,000 JPY
Net cash provided by (used in) financing activities
-52,012,000 JPY
18,236,000 JPY
2,658,538,000 JPY
229,206,000 JPY
488,905,000 JPY
Cash and cash equivalents
2,052,570,000 JPY
2,873,773,000 JPY
3,437,307,000 JPY
1,613,040,000 JPY
1,272,879,000 JPY
Number of employees
21 xbrli:pure
21 xbrli:pure
21 xbrli:pure
22 xbrli:pure
19 xbrli:pure
Average number of temporary employees
1 xbrli:pure
1 xbrli:pure
1 xbrli:pure
2 xbrli:pure
2 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.